EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.42
+2.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.53x
- Price / sales
- 7.91x
- Price / cash flow
- -3.10x
Enterprise value
- Enterprise value
- $175.5M
- EV / sales
- 3.73x
- EV / EBITDA
- -2.50x
- EV / EBIT
- -2.14x
- Market cap
- $371.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026